Prenetics Global Ltd (PRE) Form 6-K — Aug 26, 2026
Prenetics Global (NASDAQ: PRE) disclosed that CEO Danny Yeung and CFO Brian Rosin purchased $1.0 million of the company's ordinary shares in the open market between August 20 and August 25, 2026, within the trading window following second quarter results. Since November 2025, leadership has invested approximately $3.75 million cumulatively without selling a single share. Yeung's latest purchase of 24,681 shares at roughly $20.34 brings his personal investment to about $1.75 million, while Rosin bought 23,100 shares at roughly $21.54 in his first open market purchase since joining the company in May 2026.
Key figures
- Revenue
- 46500000
- Guidance
- FY2026 revenue guidance raised to $220-230 million; FY2027 revenue guidance introduced at more than $400 million
- Revenue Yoy
- approximately 288%
- Daily servings
- well over 200,000
- Im8 q2 revenue
- $45.0 million, up approximately 359% YoY
- Im8 july revenue
- $20.9 million
- Countries shipped
- 46
- Rosin average price
- approximately $21.54
- Yeung average price
- approximately $20.34
- Rosin purchase amount
- approximately $498,000
- Yeung purchase amount
- approximately $502,000
- Rosin shares purchased
- 23100
- Yeung shares purchased
- 24681
- Im8 annualized run rate
- approximately $251 million
- August insider purchases
- $1.0 million combined (August 20-25, 2026)
- Consecutive record quarters
- 6
- General catalyst commitment
- $1 billion Customer Value Fund growth financing
- Yeung cumulative investment
- approximately $1.75 million
- Cumulative leadership investment
- approximately $3.75 million since November 2025
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.